Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Phoenix Ho, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
128 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, Australia
- Monash Medical Centre
Clayton, Australia
- St George Hospital
Kogarah, Australia
- Royal Perth Hospital
Perth, Australia
- Sunshine Hospital
St Albans, Australia
- Lkh Salzburg, Universitatsklinikum Der Pmu
Salzburg, Austria
- Klinikum Wels-Grieskirchen Gmbh
Wels, Austria
- Ziekenhuis Netwerk Antwerpen Campus Stuivenberg
Antwerp, Belgium
- Az Sint-Jane Brugge - Oostende Av - Campus Sint-Jan
Bruges, Belgium
- Cliniques Universitaires Saint Luc
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- Centre Hospitalier Universitaire Sart Tilman Liege
Liège, Belgium
- Az Delta - Campus Wilgenstraat
Roeselare, Belgium
- Cliniques Universitaires Ucl de Mont-Goddine
Yvoir, Belgium
- Fakultni Nemocnice Brno
Brno, Czechia
- Fakultni Nemocnice Hradec Kralove-Oddeleni Klinicke Hematologie
Hradec Králové, Czechia
- Fakultni Nemocnice Ostrava
Ostrava - Poruba, Czechia
- Ustav Hematologie A Krevni Transfuze
Prague, Czechia
- Chu Amiens Picardie - Site Sud
Amiens, France
- Center Hospitalier Universitaire D' Angers
Angers, France
- Centre Hospitalier Victor Dupouy D'Argenteuil
Argenteuil, France
- Centre Hospitalier Universitaire Hopital Avicenne
Bobigny, France
- Hopital D'Instruction Des Armees - Percy
Clamart, France
- Chru de Lille
Lille, France
- Centre Hospitalier Universitaire (chu) de Limoges - Hopital Dupuytren
Limoges, France
- Hopital Emile Muller
Mulhouse, France
- Centre Hospitalier Universitaire Nantes-Hotel Dieu
Nantes, France
- Chu de Nice - Hopital L'Archet
Nice, France
- Hopital Saint-Louis / Service D'Hematologie
Paris, France
- Chu Bordeaux Hopital Haut-Levaque
Pessac, France
- Centre Hospitalier Lyon Sud
Pierre-Bénite, France
- Centre Hospitalier Universitaire de Poitiers
Poitiers, France
- Centre Hospitalier Universitaire de Rennes, Hopital Pontchaillou
Rennes, France
- Stadtisches Klinikum Braunschweig Ggmbh
Braunschweig, Germany
- Universitatsklinikum Koln
Cologne, Germany
- Marien Hospital Dusseldorf Gmbh
Düsseldorf, Germany
- Universitatsklinik Freiburg
Freiburg im Breisgau, Germany
- Universitatsklinikum Schleswig-Holstein
Kiel, Germany
- Semmelweis Egyetem
Budapest, Hungary
- Debreceni Egyetem Orvos és Egeszsegtudomanyi Centrum, Iii. Sz. Belgyogyaszati Klinika
Debrecen, Hungary
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2016
- Primary completion
- 3 Oct 2017
- Completion
- 3 Oct 2017
- Last update posted
- 12 Dec 2018
- Registered enrollment
- 240
- Registry id
- NCT02785900
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.